Global Next Generation Cancer Diagnostics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16187828 | Publishing Date : 19-Aug-2020
Detailed TOC of Global Next Generation Cancer Diagnostics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Next Generation Cancer Diagnostics1.1 Next Generation Cancer Diagnostics Market Overview
1.1.1 Next Generation Cancer Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next Generation Cancer Diagnostics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Next Generation Cancer Diagnostics Market Size by Region (2015-2026)
1.4 Global Next Generation Cancer Diagnostics Historic Market Size by Region (2015-2020)
1.5 Global Next Generation Cancer Diagnostics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026)
1.6.1 North America Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026)
1.6.2 Europe Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026)
1.6.4 Latin America Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026)
2 Next Generation Cancer Diagnostics Market Overview by Type
2.1 Global Next Generation Cancer Diagnostics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Next Generation Cancer Diagnostics Historic Market Size by Type (2015-2020)
2.3 Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2021-2026)
2.4 Next Generation Sequencing
2.5 qPCR & Multiplexing
2.6 DNA Microarrays
2.7 Other
3 Next Generation Cancer Diagnostics Market Overview by Application
3.1 Global Next Generation Cancer Diagnostics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Next Generation Cancer Diagnostics Historic Market Size by Application (2015-2020)
3.3 Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinics
3.6 Other
4 Global Next Generation Cancer Diagnostics Competition Analysis by Players
4.1 Global Next Generation Cancer Diagnostics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostics as of 2019)
4.3 Date of Key Manufacturers Enter into Next Generation Cancer Diagnostics Market
4.4 Global Top Players Next Generation Cancer Diagnostics Headquarters and Area Served
4.5 Key Players Next Generation Cancer Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Next Generation Cancer Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Cepheid
5.1.1 Cepheid Profile
5.1.2 Cepheid Main Business
5.1.3 Cepheid Products, Services and Solutions
5.1.4 Cepheid Revenue (US$ Million) & (2015-2020)
5.1.5 Cepheid Recent Developments
5.2 Koninklijke Philips N.V
5.2.1 Koninklijke Philips N.V Profile
5.2.2 Koninklijke Philips N.V Main Business and Company’s Total Revenue
5.2.3 Koninklijke Philips N.V Products, Services and Solutions
5.2.4 Koninklijke Philips N.V Revenue (US$ Million) (2015-2020)
5.2.5 Koninklijke Philips N.V Recent Development and Reaction to Covid-19
5.3 F. Hoffmann-La Roche Ltd
5.5.1 F. Hoffmann-La Roche Ltd Profile
5.3.2 F. Hoffmann-La Roche Ltd Main Business
5.3.3 F. Hoffmann-La Roche Ltd Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Ltd Revenue (US$ Million) & (2015-2020)
5.3.5 Qiagen Recent Developments
5.4 Qiagen
5.4.1 Qiagen Profile
5.4.2 Qiagen Main Business
5.4.3 Qiagen Products, Services and Solutions
5.4.4 Qiagen Revenue (US$ Million) & (2015-2020)
5.4.5 Qiagen Recent Developments
5.5 Novartis AG
5.5.1 Novartis AG Profile
5.5.2 Novartis AG Main Business
5.5.3 Novartis AG Products, Services and Solutions
5.5.4 Novartis AG Revenue (US$ Million) & (2015-2020)
5.5.5 Novartis AG Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Products, Services and Solutions
5.6.4 Abbott Revenue (US$ Million) & (2015-2020)
5.6.5 Abbott Recent Developments
5.7 Thermo Fisher Scientific
5.7.1 Thermo Fisher Scientific Profile
5.7.2 Thermo Fisher Scientific Main Business and Company’s Total Revenue
5.7.3 Thermo Fisher Scientific Products, Services and Solutions
5.7.4 Thermo Fisher Scientific Revenue (US$ Million) (2015-2020)
5.7.5 Thermo Fisher Scientific Recent Development and Reaction to Covid-19
5.8 Opko Health
5.8.1 Opko Health Profile
5.8.2 Opko Health Main Business
5.8.3 Opko Health Products, Services and Solutions
5.8.4 Opko Health Revenue (US$ Million) & (2015-2020)
5.8.5 Opko Health Recent Developments
5.9 Myriad Genetics
5.9.1 Myriad Genetics Profile
5.9.2 Myriad Genetics Main Business
5.9.3 Myriad Genetics Products, Services and Solutions
5.9.4 Myriad Genetics Revenue (US$ Million) & (2015-2020)
5.9.5 Myriad Genetics Recent Developments
5.10 Agilent Technologies
5.10.1 Agilent Technologies Profile
5.10.2 Agilent Technologies Main Business
5.10.3 Agilent Technologies Products, Services and Solutions
5.10.4 Agilent Technologies Revenue (US$ Million) & (2015-2020)
5.10.5 Agilent Technologies Recent Developments
5.11 GE Healthcare
5.11.1 GE Healthcare Profile
5.11.2 GE Healthcare Main Business
5.11.3 GE Healthcare Products, Services and Solutions
5.11.4 GE Healthcare Revenue (US$ Million) & (2015-2020)
5.11.5 GE Healthcare Recent Developments
5.12 PerkinElmer
5.12.1 PerkinElmer Profile
5.12.2 PerkinElmer Main Business
5.12.3 PerkinElmer Products, Services and Solutions
5.12.4 PerkinElmer Revenue (US$ Million) & (2015-2020)
5.12.5 PerkinElmer Recent Developments
5.13 Genomic Health
5.13.1 Genomic Health Profile
5.13.2 Genomic Health Main Business
5.13.3 Genomic Health Products, Services and Solutions
5.13.4 Genomic Health Revenue (US$ Million) & (2015-2020)
5.13.5 Genomic Health Recent Developments
5.14 Illumina
5.14.1 Illumina Profile
5.14.2 Illumina Main Business
5.14.3 Illumina Products, Services and Solutions
5.14.4 Illumina Revenue (US$ Million) & (2015-2020)
5.14.5 Illumina Recent Developments
5.15 Hologic
5.15.1 Hologic Profile
5.15.2 Hologic Main Business
5.15.3 Hologic Products, Services and Solutions
5.15.4 Hologic Revenue (US$ Million) & (2015-2020)
5.15.5 Hologic Recent Developments
5.16 Almac Group
5.16.1 Almac Group Profile
5.16.2 Almac Group Main Business and Company’s Total Revenue
5.16.3 Almac Group Products, Services and Solutions
5.16.4 Almac Group Revenue (US$ Million) (2015-2020)
5.16.5 Almac Group Recent Development and Reaction to Covid-19
5.17 Janssen Global Services
5.17.1 Janssen Global Services Profile
5.17.2 Janssen Global Services Main Business
5.17.3 Janssen Global Services Products, Services and Solutions
5.17.4 Janssen Global Services Revenue (US$ Million) & (2015-2020)
5.17.5 Janssen Global Services Recent Developments
5.18 Sysmex Corporation
5.18.1 Sysmex Corporation Profile
5.18.2 Sysmex Corporation Main Business
5.18.3 Sysmex Corporation Products, Services and Solutions
5.18.4 Sysmex Corporation Revenue (US$ Million) & (2015-2020)
5.18.5 Sysmex Corporation Recent Developments
6 North America
6.1 North America Next Generation Cancer Diagnostics Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Next Generation Cancer Diagnostics Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Next Generation Cancer Diagnostics Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Next Generation Cancer Diagnostics Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Next Generation Cancer Diagnostics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Next Generation Cancer Diagnostics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Next Generation Cancer Diagnostics Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Next Generation Cancer Diagnostics Market Size Share by Region (2015-2020)
Table 4. Global Next Generation Cancer Diagnostics Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Next Generation Cancer Diagnostics Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Next Generation Cancer Diagnostics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Next Generation Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2015-2020)
Table 9. Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2021-2026)
Table 11. Global Next Generation Cancer Diagnostics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Next Generation Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2015-2020)
Table 14. Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2021-2026)
Table 16. Global Next Generation Cancer Diagnostics Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostics as of 2019)
Table 19. Date of Key Manufacturers Enter into Next Generation Cancer Diagnostics Market
Table 20. Global Next Generation Cancer Diagnostics Top Players Headquarters and Area Served
Table 21. Next Generation Cancer Diagnostics Product Solution and Service
Table 22. Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Cepheid Basic Information List
Table 25. Cepheid Description and Business Overview
Table 26. Cepheid Next Generation Cancer Diagnostics Products, Services and Solutions
Table 27. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Cepheid (2015-2020)
Table 28. Cepheid Recent Developments
Table 29. Koninklijke Philips N.V Basic Information List
Table 30. Koninklijke Philips N.V Description and Business Overview
Table 31. Koninklijke Philips N.V Next Generation Cancer Diagnostics Products, Services and Solutions
Table 32. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Koninklijke Philips N.V (2015-2020)
Table 33. Koninklijke Philips N.V Recent Developments
Table 34. F. Hoffmann-La Roche Ltd Basic Information List
Table 35. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 36. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Products, Services and Solutions
Table 37. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of F. Hoffmann-La Roche Ltd (2015-2020)
Table 38. F. Hoffmann-La Roche Ltd Recent Developments
Table 39. Qiagen Basic Information List
Table 40. Qiagen Description and Business Overview
Table 41. Qiagen Next Generation Cancer Diagnostics Products, Services and Solutions
Table 42. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Qiagen (2015-2020)
Table 43. Qiagen Recent Developments
Table 44. Novartis AG Basic Information List
Table 45. Novartis AG Description and Business Overview
Table 46. Novartis AG Next Generation Cancer Diagnostics Products, Services and Solutions
Table 47. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Novartis AG (2015-2020)
Table 48. Novartis AG Recent Developments
Table 49. Abbott Basic Information List
Table 50. Abbott Description and Business Overview
Table 51. Abbott Next Generation Cancer Diagnostics Products, Services and Solutions
Table 52. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Abbott (2015-2020)
Table 53. Abbott Recent Developments
Table 54. Thermo Fisher Scientific Basic Information List
Table 55. Thermo Fisher Scientific Description and Business Overview
Table 56. Thermo Fisher Scientific Next Generation Cancer Diagnostics Products, Services and Solutions
Table 57. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Thermo Fisher Scientific (2015-2020)
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Opko Health Basic Information List
Table 60. Opko Health Description and Business Overview
Table 61. Opko Health Next Generation Cancer Diagnostics Products, Services and Solutions
Table 62. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Opko Health (2015-2020)
Table 63. Opko Health Recent Developments
Table 64. Myriad Genetics Basic Information List
Table 65. Myriad Genetics Description and Business Overview
Table 66. Myriad Genetics Next Generation Cancer Diagnostics Products, Services and Solutions
Table 67. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Myriad Genetics (2015-2020)
Table 68. Myriad Genetics Recent Developments
Table 69. Agilent Technologies Basic Information List
Table 70. Agilent Technologies Description and Business Overview
Table 71. Agilent Technologies Next Generation Cancer Diagnostics Products, Services and Solutions
Table 72. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Agilent Technologies (2015-2020)
Table 73. Agilent Technologies Recent Developments
Table 74. GE Healthcare Basic Information List
Table 75. GE Healthcare Description and Business Overview
Table 76. GE Healthcare Next Generation Cancer Diagnostics Products, Services and Solutions
Table 77. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of GE Healthcare (2015-2020)
Table 78. GE Healthcare Recent Developments
Table 79. PerkinElmer Basic Information List
Table 80. PerkinElmer Description and Business Overview
Table 81. PerkinElmer Next Generation Cancer Diagnostics Products, Services and Solutions
Table 82. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of PerkinElmer (2015-2020)
Table 83. PerkinElmer Recent Developments
Table 84. Genomic Health Basic Information List
Table 85. Genomic Health Description and Business Overview
Table 86. Genomic Health Next Generation Cancer Diagnostics Products, Services and Solutions
Table 87. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Genomic Health (2015-2020)
Table 88. Genomic Health Recent Developments
Table 89. Illumina Basic Information List
Table 90. Illumina Description and Business Overview
Table 91. Illumina Next Generation Cancer Diagnostics Products, Services and Solutions
Table 92. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Illumina (2015-2020)
Table 93. Illumina Recent Developments
Table 94. Hologic Basic Information List
Table 95. Hologic Description and Business Overview
Table 96. Hologic Next Generation Cancer Diagnostics Products, Services and Solutions
Table 97. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Hologic (2015-2020)
Table 98. Hologic Recent Developments
Table 99. Almac Group Basic Information List
Table 100. Almac Group Description and Business Overview
Table 101. Almac Group Next Generation Cancer Diagnostics Products, Services and Solutions
Table 102. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Almac Group (2015-2020)
Table 103. Almac Group Recent Developments
Table 104. Janssen Global Services Basic Information List
Table 105. Janssen Global Services Description and Business Overview
Table 106. Janssen Global Services Next Generation Cancer Diagnostics Products, Services and Solutions
Table 107. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Janssen Global Services (2015-2020)
Table 108. Janssen Global Services Recent Developments
Table 109. Sysmex Corporation Basic Information List
Table 110. Sysmex Corporation Description and Business Overview
Table 111. Sysmex Corporation Next Generation Cancer Diagnostics Products, Services and Solutions
Table 112. Revenue (Million US$) in Next Generation Cancer Diagnostics Business of Sysmex Corporation (2015-2020)
Table 113. Sysmex Corporation Recent Developments
Table 114. North America Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million)
Table 115. North America Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020)
Table 116. Europe Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million)
Table 117. Europe Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020)
Table 118. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million)
Table 119. Asia-Pacific Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020) (US$ Million)
Table 120. Latin America Next Generation Cancer Diagnostics Market Size by Country (2015-2020) & (US$ Million)
Table 121. Latin America Next Generation Cancer Diagnostics Market Size Share by Country (2015-2020) (US$ Million)
Table 122. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Players (2015-2020) (US$ Million)
Table 123. Middle East & Africa Next Generation Cancer Diagnostics Market Size Share by Players (2015-2020) (US$ Million)
Table 124. Next Generation Cancer Diagnostics Market Trends
Table 125. Next Generation Cancer Diagnostics Market Drivers
Table 126. Next Generation Cancer Diagnostics Market Challenges
Table 127. Next Generation Cancer Diagnostics Market Restriants
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Cancer Diagnostics Market Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Next Generation Cancer Diagnostics Market Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Next Generation Cancer Diagnostics Market Share by Regions: 2020 VS 2026
Figure 4. North America Next Generation Cancer Diagnostics Market Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Next Generation Cancer Diagnostics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Next Generation Cancer Diagnostics Market Share by Type in 2020 & 2026
Figure 10. Next Generation Sequencing Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. qPCR & Multiplexing Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. DNA Microarrays Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Other Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Global Next Generation Cancer Diagnostics Market Size Share by Application in 2020 & 2026
Figure 15. Hospitals Market Size (US$ Million) YoY Growth (2015-2026)
Figure 16. Clinics Market Size (US$ Million) YoY Growth (2015-2026)
Figure 17. Other Market Size (US$ Million) YoY Growth (2015-2026)
Figure 18. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Top 5 and Top 10 Players Next Generation Cancer Diagnostics Market Share in 2019
Figure 20. United States Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Rest of Latin America Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Keyplayers in Global Next Generation Cancer Diagnostics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
CepheidKoninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation